ProMIS Neurosciences Inc. (PMN): who owns it and who trades it
As of Nov 16, 2026, PMN insiders reported 11 purchases worth $8.9M in the last 12 months. The largest buyer was Fan Yu (10% owner), with $8.5M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling ProMIS Neurosciences
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PMN
27 funds and institutions reported PMN shares worth $84.3M at the end of Q2 2026, about 71% of the company. The largest holder is Jupiter Topco LLC with 14.4%.
Funds and institutions (13F) 71%Everyone else 29%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Jupiter Topco LLC | 1.29M | 14.42% | $17M | New |
| Deep Track Capital, LP | 835,655 | 9.32% | $11M | No change |
| Wellington Management Group LLP | 696,378 | 7.77% | $9.2M | No change |
| Ally Bridge Group (NY) LLC | 620,319 | 6.92% | $8.2M | +50% |
| Trails Edge Capital Partners, LP | 557,103 | 6.21% | $7.3M | No change |
| Woodline Partners LP | 441,911 | 4.93% | $5.8M | +12% |
| Yu Fan | 329,760 | 3.68% | $4.3M | No change |
| Sphera Funds Management Ltd. | 325,591 | 3.63% | $4.3M | No change |
| Squadron Capital Management LLC | 324,977 | 3.62% | $4.3M | No change |
| Ikarian Capital, LLC | 205,000 | 2.29% | $2.7M | +273% |
| Ameriprise Financial Inc | 185,700 | 2.07% | $2.4M | New |
| Adage Capital Partners Gp, L.l.c. | 164,275 | 1.83% | $2.2M | +18% |
| 683 Capital Management, LLC | 95,000 | 1.06% | $1.3M | +2% |
| ADAR1 Capital Management, LLC | 92,850 | 1.04% | $1.2M | -3% |
| Great Point Partners LLC | 86,150 | 0.96% | $1.1M | -77% |
| Boothbay Fund Management, LLC | 62,078 | 0.69% | $817K | +287% |
| Millennium Management LLC | 56,045 | 0.62% | $738K | -28% |
| Bank of Montreal | 11,371 | 0.13% | $150K | New |
| Seven Fleet Capital Management LP | 10,600 | 0.12% | $139K | No change |
| Morgan Stanley | 7,559 | 0.08% | $99.5K | New |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PMN insiders reported $8.9M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Eugene Williams | Director | Purchase | 26,500 | $3.43 | $90.9K | Form 4 |
| Nov 2, 2026 | Neil Cashman | Director | Purchase | 10,000 | $3.86 | $38.6K | Form 4 |
| Oct 30, 2026 | Eugene Williams | Director | Purchase | 1,316 | $3.99 | $5.3K | Form 4 |
| Aug 5, 2026 | Johanne Kaplan | Chief Development Office | Purchase | 2,280 | $13.30 | $30.3K | Form 4 |
| Apr 22, 2026 | Patrick D. Kirwin | Director | Purchase | 4,000 | $11.33 | $45.3K | Form 4 |
| Mar 5, 2026 | Eugene Williams | Director | Purchase | 2,000 | $24.40 | $48.8K | Form 4 |
| Mar 4, 2026 | Eugene Williams | Director | Purchase | 2,000 | $24.00 | $48K | Form 4 |
| Mar 3, 2026 | Eugene Williams | Director | Purchase | 1,000 | $21.89 | $21.9K | Form 4 |
| Mar 2, 2026 | Eugene Williams | Director | Purchase | 1,000 | $22.53 | $22.5K | Form 4 |
| Feb 19, 2026 | Johanne Kaplan | Chief Development Office | Purchase | 1,629 | $15.35 | $25K | Form 4 |
| Feb 3, 2026 | Fan Yu +4 | 10% owner | Purchase | 700,741 | $12.13 | $8.5M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Fan Yu | 10% owner | $8.5M | – | Feb 3, 2026 |
| Eugene Williams | Director | $237K | – | Nov 4, 2026 |
| Johanne Kaplan | Chief Development Officer | $55.3K | – | Aug 5, 2026 |
| Patrick D. Kirwin | Director | $45.3K | – | Apr 22, 2026 |
| Neil Cashman | Chief Scientific Officer, Director | $38.6K | – | Nov 2, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PMN short interest
Low short interest. 3.1% of PMN shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 65%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 274,761 PMN shares were sold short, 3.1% of the shares outstanding, up 11.8% from the report before. At the average daily volume of 178,207 shares, buying them all back would take about 1.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 274,761 | 3.06% | +12% | 178,207 | 1.5 |
| Oct 15, 2026 | 245,838 | 2.74% | +3% | 34,430 | 7.1 |
| Sep 30, 2026 | 238,584 | 2.66% | -1% | 33,526 | 7.1 |
| Sep 15, 2026 | 240,000 | 2.68% | -9% | 49,944 | 4.8 |
| Aug 31, 2026 | 263,744 | 2.94% | -6% | 28,029 | 9.4 |
| Aug 14, 2026 | 281,134 | 3.13% | -1% | 26,135 | 10.8 |
| Jul 31, 2026 | 283,726 | 3.16% | +20% | 267,082 | 1.1 |
| Jul 15, 2026 | 235,779 | 2.63% | +16% | 75,219 | 3.1 |
| Jun 30, 2026 | 203,926 | 2.27% | +2% | 42,090 | 4.8 |
| Jun 15, 2026 | 200,865 | 2.24% | +6% | 19,570 | 10.3 |
| May 29, 2026 | 188,790 | 2.11% | +13% | 22,074 | 8.6 |
| May 15, 2026 | 166,588 | 1.86% | +18% | 35,869 | 4.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
ProMIS Neurosciences company events
ProMIS Neurosciences filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Aug 13, 2026.
- Aug 13, 2026ResultsReleased financial results. Filing
- Jul 28, 2026AnnouncementThe Company issued the Press Release. Filing
- May 20, 2026LeadershipAs further described in Item 5.07 below, the stockholders of ProMIS Neurosciences Inc. approved an amendment to the Company’s 2025 Stock Option and Incentive Plan at the Company’s 2026 Annual Meeting of Stockholders held on May 20, 2026. Filing
- May 12, 2026ResultsReleased financial results. Filing
- Mar 25, 2026ResultsReleased financial results. Filing
- Jan 30, 2026AgreementProMIS Neurosciences Inc. entered into a Securities Purchase Agreement with selected investors that qualify as “accredited investors”, as defined in Rule 501(a) of Regulation D promulgated under the United States Securities Act of 1933, as amended, for the purpose of raising approximately $75… Filing
- Dec 16, 2025AnnouncementProMIS Neurosciences Inc. received a written notification from the Nasdaq Stock Market Listing Qualifications Staff indicating that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to NASDAQ Listing Rule… Filing
- Nov 24, 2025AnnouncementThe Company issued a press release announcing the Reverse Stock Split and other related information. Filing
- Nov 19, 2025VoteReported shareholder vote results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
ProMIS Neurosciences financials
Famous investors that hold PMN
2 of the 50 well-known investors we track reported holding PMN in their latest 13F filing. The largest position is Israel Englander's, worth $1.3M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 121,123 | $1.3M | 0.0% | +116% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 22,902 | $248K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PMN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Great Point Partners, LLC | 13G/A | 6.8% |
| Nov 16, 2026 | Great Point Partners, LLC | 13G/A | 6.8% |
| Nov 12, 2026 | Adage Capital Management, L.P. | 13G | 7.7% |
| Nov 12, 2026 | Adage Capital Management, L.P. | 13G | 7.7% |
Questions about ProMIS Neurosciences Inc. (PMN) stock
Who owns the most PMN stock?
The largest reported owner of ProMIS Neurosciences Inc. (PMN) is Jupiter Topco LLC, with 14.4% of the company. In total, 27 funds and institutions reported holding PMN at the end of Q2 2026, together about 71% of the shares. See the largest owners.
Are PMN insiders buying or selling?
In the last 12 months, PMN insiders reported 11 open-market purchases worth $8.9M and no sales. The latest trade was on Nov 4, 2026. See every trade.
What is the short interest in PMN?
As of Oct 30, 2026, 274,761 PMN shares were sold short, 3.1% of the shares outstanding, up 11.8% from the report before. At the average daily volume of 178,207 shares, buying them all back would take about 1.5 trading days (days to cover). See the history.
Which famous investors hold PMN?
2 of the 50 well-known investors we track reported PMN in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $1.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.